Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management
- 12 January 2026
- journal article
- Published by The Endocrine Society in Endocrine Reviews
- Vol. 47 (3) , 351-374
Abstract
This narrative review aims to provide a comprehensive synthesis of current knowledge and guidelines on lung carcinoids, emphasizing the multidimensional approach required for effective diagnosis and management. The manuscript will: (i) define and classify lung carcinoids in accordance with the latest WHO classification system, and emphasize the importance of molecular markers for precise subtyping; (ii) analyze epidemiological trends, discuss prevalence, incidence, and mortality rates, alongside key risk factors including genetic predispositions (MEN1) and precursor lesions such as diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH); (iii) investigate the etiology and carcinogenesis of lung carcinoids, including insights into the molecular hallmarks and pathways that underlie tumor development and progression; (iv) detail clinical presentations, distinguishing pulmonary symptoms from secretory syndromes (carcinoid syndrome and Cushing syndrome), supported by visual aids to elucidate symptom prevalence and implications; (v) present an integrated diagnostic approach, encompassing state-of-the-art imaging modalities (CT, magnetic resonance imaging [MRI], 68Ga-SSA-positron emission tomography [PET]-CT) and advanced molecular pathology techniques; (vi) outline evidence-based treatment strategies, addressing early-stage interventions, systemic therapies, locoregional therapies, and emerging modalities such as immunotherapy and agnostic approaches; (vii) explore the role of multidisciplinary management, highlighting the critical importance of tumor boards dedicated to lung carcinoids and provide a checklist of key items for comprehensive case discussion and decision-making; and (viii) conclude with future perspectives, identifying gaps in current knowledge and suggest directions for research to enhance diagnosis, treatment, and overall patient quality of life.Keywords
This publication has 171 references indexed in Scilit:
- The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunitiesReviews in Endocrine and Metabolic Disorders, 2022
- The single‐cell transcriptional landscape of lung carcinoid tumorsInternational Journal of Cancer, 2022
- Diagnosis of atypical carcinoid can be made on biopsies > 4 mm2 and is accurateVirchows Archiv, 2022
- Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51‐Case Cohort StudyWorld Journal of Surgery, 2017
- Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PETEuropean Journal of Nuclear Medicine and Molecular Imaging, 2015
- Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumorsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2015
- Long-term results of PRRT in advanced bronchopulmonary carcinoidEuropean Journal of Nuclear Medicine and Molecular Imaging, 2015
- Bronchopulmonary neuroendocrine tumorsCancer, 2008
- Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasiaPediatric Pulmonology, 2005
- Detection of pulmonary nodules by multislice computed tomography: improved detection rate with reduced slice thicknessEuropean Radiology, 2003